These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9583027)

  • 1. [Argon plasma coagulation in treatment of hereditary hemorrhagic telangiectasia of the nasal mucosa].
    Bergler W; Götte K; Riedel F; Back W; Hörmann K
    HNO; 1998 Mar; 46(3):228-32. PubMed ID: 9583027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Argon plasma coagulation for the treatment of hereditary hemorrhagic telangiectasia.
    Bergler W; Riedel F; Baker-Schreyer A; Juncker C; Hörmann K
    Laryngoscope; 1999 Jan; 109(1):15-20. PubMed ID: 9917033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of haemorrhagic telangiectasia with the flashlamp-pulsed dye laser.
    Ducic Y; Brownrigg P; Laughlin S
    J Otolaryngol; 1995 Oct; 24(5):299-302. PubMed ID: 8537990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma surgery and topical estriol: effects on the nasal mucosa and long-term results in patients with Osler's disease.
    Sadick H; Naim R; Oulmi J; Hörmann K; Bergler W
    Otolaryngol Head Neck Surg; 2003 Sep; 129(3):233-8. PubMed ID: 12958572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of recurrent epistaxis in Rendu-Osler-Weber disease].
    Werner JA; Geisthoff UW; Lippert BM; Rudert H
    HNO; 1997 Sep; 45(9):673-81. PubMed ID: 9417448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Argon plasma coagulation and topically applied estriol. Long-term results in the treatment of hereditary hemorrhagic telangiectasia of the nasal mucosa].
    Sadick H; Riedel F; Oulmi J; Hörmann K; Bergler WF
    HNO; 2003 Feb; 51(2):118-24. PubMed ID: 12589417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nasal cavity dermoplasty as a treatment of recurrent bleeding in Rendu-Osler-Weber's disease].
    Kłos A; Golqbek W; Morshed K
    Otolaryngol Pol; 2007; 61(1):74-9. PubMed ID: 17605423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of severity of epistaxis with nasal telangiectasias in hereditary hemorrhagic telangiectasia (HHT) patients.
    Pagella F; Colombo A; Matti E; Giourgos G; Tinelli C; Olivieri C; Danesino C
    Am J Rhinol Allergy; 2009; 23(1):52-8. PubMed ID: 19379613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New classification of nasal vasculature patterns in hereditary hemorrhagic telangiectasia.
    Mahoney EJ; Shapshay SM
    Am J Rhinol; 2006; 20(1):87-90. PubMed ID: 16539301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using the KTP/532 laser to control epistaxis in patients with hereditary hemorrhagic telangiectasia.
    Vickery CL; Kuhn FA
    South Med J; 1996 Jan; 89(1):78-80. PubMed ID: 8545698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical estrogens combined with argon plasma coagulation in the management of epistaxis in hereditary hemorrhagic telangiectasia.
    Bergler W; Sadick H; Gotte K; Riedel F; Hörmann K
    Ann Otol Rhinol Laryngol; 2002 Mar; 111(3 Pt 1):222-8. PubMed ID: 11913682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free-flap reconstruction for the management of life-threatening hereditary hemorrhagic telangiectasia.
    Choi JW; Joo YH; Jeong WS; Jang YJ
    Auris Nasus Larynx; 2017 Oct; 44(5):607-611. PubMed ID: 27616747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric predominant hereditary hemorrhagic telangiectasia.
    Katsinelos P; Chatzimavroudis G; Zavos C; Kamperis E; Triantafillidis I; Pilpilidis I; Katsinelos T; Papaziogas B
    Vasa; 2006 Nov; 35(4):258-61. PubMed ID: 17109371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective study of the role of the argon laser in the management of epistaxis secondary to hereditary haemorrhagic telangiectasia.
    Lennox PA; Harries M; Lund VJ; Howard DJ
    J Laryngol Otol; 1997 Jan; 111(1):34-7. PubMed ID: 9292128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical application of timolol decreases the severity and frequency of epistaxis in patients who have previously undergone nasal dermoplasty for hereditary hemorrhagic telangiectasia.
    Ichimura K; Kikuchi H; Imayoshi S; Dias MS
    Auris Nasus Larynx; 2016 Aug; 43(4):429-32. PubMed ID: 26739947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical management of life-threatening epistaxis in Osler-Weber-Rendu disease.
    Rebeiz EE; Bryan DJ; Ehrlichman RJ; Shapshay SM
    Ann Plast Surg; 1995 Aug; 35(2):208-13. PubMed ID: 7486747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical 22-case study of hereditary hemorrhagic telangiectasia subjects undergoing nasal dermoplasty].
    Kikuchi H; Imayoshi S; Yamauchi T; Ichimura K
    Nihon Jibiinkoka Gakkai Kaiho; 2012 Feb; 115(2):108-11. PubMed ID: 22568130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of treatment for epistaxis secondary to hereditary hemorrhagic telangiectasia.
    Hitchings AE; Lennox PA; Lund VJ; Howard DJ
    Am J Rhinol; 2005; 19(1):75-8. PubMed ID: 15794079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Argon plasma coagulation is an effective treatment for hereditary hemorrhagic telangiectasia patients with severe nosebleeds.
    Pagella F; Matti E; Chu F; Pusateri A; Tinelli C; Olivieri C; Canzonieri C; Boeri L; Ornati F; Danesino C
    Acta Otolaryngol; 2013 Feb; 133(2):174-80. PubMed ID: 23066781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laser-Assisted Control of Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Systematic Review.
    Abiri A; Goshtasbi K; Maducdoc M; Sahyouni R; Wang MB; Kuan EC
    Lasers Surg Med; 2020 Apr; 52(4):293-300. PubMed ID: 31441079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.